Longevity research has exploded over the past decade, and peptides sit right at the centre of it. Unlike broad-spectrum supplements or single-target pharmaceuticals, peptides offer highly specific signalling activity — which is exactly what makes them so useful for studying the mechanisms behind ageing. Here are ten peptides that keep coming up in the longevity literature, and why researchers are interested in each one.
Epitalon is probably the most directly “anti-ageing” peptide on this list. It is a synthetic version of a naturally occurring peptide called Epithalamin, produced by the pineal gland. The primary mechanism of interest is its apparent ability to activate telomerase — the enzyme responsible for maintaining telomere length. Telomere shortening is one of the hallmarks of cellular ageing, so a compound that can slow or reverse that process is always going to get attention.
Animal studies dating back to the early 2000s showed lifespan extension in rodent models, and more recent in vitro work has confirmed telomerase activation in human cell lines. It also appears to regulate melatonin production, which ties into circadian rhythm and sleep quality — both of which degrade with age.
We have covered BPC-157 in more detail elsewhere on this blog, but it earns a spot on any longevity list for its biological structure-protective properties. The idea is straightforward: if you can accelerate recovery and reduce chronic inflammation, you are addressing two of the biggest contributors to age-related decline. BPC-157’s angiogenic properties and interaction with the nitric oxide system give it a broad repair profile across tendon, muscle, gut, and even neural biological structure in preclinical models.
Mitochondrial dysfunction is a core driver of ageing. As we get older, mitochondria become less efficient at producing ATP, and they generate more reactive oxygen species in the process. SS-31 targets this directly. It is a cell-permeable peptide that concentrates in the inner mitochondrial membrane, where it stabilises cardiolipin — a phospholipid essential for electron transport chain function.
Studies have shown SS-31 can restore mitochondrial function in aged cells, reduce oxidative stress, and improve cardiac and skeletal muscle performance in ageing animal models. It is one of the few peptides that has made it into human clinical trials for age-related conditions, including heart failure and mitochondrial myopathy.
MOTS-c is a mitochondrial-derived peptide — meaning it is encoded by mitochondrial DNA rather than nuclear DNA. This is notable because it represents a communication pathway from the mitochondria to the nucleus that researchers are only beginning to understand. MOTS-c appears to regulate metabolic homeostasis by activating AMPK, a key energy-sensing enzyme that declines with age.
In animal studies, MOTS-c administration has been shown to improve insulin sensitivity, reduce fat accumulation, and enhance exercise capacity. Circulating levels of MOTS-c naturally decline with age, which suggests it may be part of the reason metabolic function deteriorates over time.
GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Plasma levels drop significantly with age — from around 200 ng/mL at age 20 to roughly 80 ng/mL by age 60. Research has shown that GHK-Cu can reset the expression of numerous genes to a more youthful state, including genes involved in DNA repair, antioxidant defence, and stem cell activity.
Beyond its well-known effects on skin remodelling and wound recovery signaling, GHK-Cu has demonstrated anti-inflammatory properties and an ability to promote cellular renewal across multiple organ systems in preclinical work. The gene expression data alone makes it one of the more fascinating molecules in the longevity space.
NAD+ (nicotinamide adenine dinucleotide) levels decline substantially with age, and this decline is linked to reduced sirtuin activity, impaired DNA repair, and mitochondrial dysfunction. While NAD+ itself is not a peptide, the research around restoring NAD+ levels intersects heavily with peptide biology. Compounds that support NAD+ biosynthesis or protect against NAD+ degradation are a major focus area, and several peptide-based approaches are under investigation for their ability to modulate this pathway.
The immune system degrades with age — a process called immunosenescence. Thymosin Alpha-1 is a thymic peptide that plays a role in T-cell maturation and immune regulation. It has been approved in several countries for immune-related conditions and has been studied for its potential to restore aspects of immune function that decline in older populations.
For longevity researchers, the interest lies in whether supporting immune competence can reduce susceptibility to infections, cancer, and chronic inflammatory states that accelerate ageing.
Growth hormone secretion drops off markedly after middle age — a phenomenon sometimes called somatopause. Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without the broader hormonal disruption associated with GHRH analogues or exogenous GH. It works by mimicking ghrelin at the GH secretagogue receptor but with a cleaner side-effect profile than many alternatives.
The relevance to longevity is the downstream effect of restored GH pulsatility: improved body composition, better sleep architecture, and enhanced recovery capacity. Whether GH optimisation actually extends lifespan is still debated, but it clearly affects quality of life markers that matter as people age.
Sleep quality is one of the first things to deteriorate with age, and poor sleep accelerates almost every other ageing process — from cognitive decline to metabolic dysfunction to immune suppression. DSIP was first isolated in the 1970s from the cerebral venous blood of rabbits during induced sleep, and it has been studied for its ability to normalise sleep patterns.
Beyond sleep, DSIP has shown stress-protective properties and may modulate cortisol and LH levels. For longevity research, the connection between restorative sleep and healthspan makes DSIP a peptide worth understanding, even if the clinical data is still limited compared to some others on this list.
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that was developed to isolate the fat-metabolising effects of GH without its growth-promoting or diabetogenic properties. It has shown an ability to stimulate lipolysis and inhibit lipogenesis in preclinical studies.
The longevity angle here is about metabolic health. Excess visceral fat is one of the strongest predictors of age-related disease, and a compound that can specifically target fat metabolism without affecting blood sugar or promoting biological structure growth has obvious appeal for researchers studying healthy ageing. AOD-9604 has also shown some interesting regenerative properties in cartilage and bone studies, adding another dimension to its potential.
The common thread across all of these peptides is specificity. Each one targets a particular mechanism that contributes to ageing — whether it is telomere maintenance, mitochondrial function, immune competence, sleep regulation, or metabolic health. The future of longevity research likely involves combining these approaches in ways that address multiple ageing pathways simultaneously.
We are still in the early chapters of this story. Most of the data is preclinical, and translating animal results to human outcomes is never straightforward. But the direction of travel is clear, and peptides are going to play a central role in whatever comes next.
All peptides mentioned in this article are sold strictly for research purposes and are not intended for human consumption. Always consult relevant regulations in your jurisdiction before purchasing or using research chemicals.
You must be 21 years or older to access this website. By entering, you confirm that you meet the minimum age requirement.
Sorry, you must be 21 or older to access this site.
For enquiries relating to compound availability, batch data, or technical documentation, please contact: info@revivaxlabs.com
